A Multicenter, Randomized, Single-Masked, Sham-Controlled, Proof-of-Concept Study of Intravitreal AL-78898A in Patients With Bilateral Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)
Latest Information Update: 27 Jan 2014
At a glance
- Drugs AL 78898A (Primary)
- Indications Age-related macular degeneration; Dry macular degeneration
- Focus Therapeutic Use
- Sponsors Alcon
- 27 Jan 2014 New trial record